GlassScriptPhysician profile
Jonathan T Donaldson
NPI 1881693026
$9,909.01
in general payments reported to CMS, 2019-2025
42 companies · $2,352 in 2025
The $2,352 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $1,095 · 2021: $481 · 2022: $1,811 · 2023: $1,500 · 2024: $1,440 · 2025: $2,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,192 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,192.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,701.10 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $1,433.52 | 2019-2025 | Ams 700, Axonics, General - Erectile Dysfunction |
| Axonics, INC. | $1,402.17 | 2020-2024 | Axonics, Bulkamid |
| Coloplast Corp | $721.70 | 2019-2025 | Speedicath |
| Janssen Biotech, INC. | $470.75 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $429.62 | 2019-2025 | Provenge |
| Neotract INC. | $366.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $262.27 | 2019-2025 | Keytruda, Zerbaxa, Lynparza |
| Pfizer INC. | $241.07 | 2019-2025 | |
| Astellas Pharma US INC | $201.80 | 2019-2023 | Myrbetriq |
| Immunitybio, INC. | $201.40 | 2025 | |
| Sumitomo Pharma America, INC. | $186.58 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $178.70 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $175.95 | 2023-2024 | Itind System |
| Teleflex LLC | $161.54 | 2023-2025 | Urolift, Barrigel |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $142.22 | 2022 | |
| Abbvie INC. | $138.73 | 2019-2025 | Botox, Lupron Depot |
| Angiodynamics, INC. | $138.09 | 2023-2025 | Nanoknife |
| Ferring Pharmaceuticals INC. | $119.22 | 2024-2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $103.56 | 2023-2025 | Yonsa |
| 180 Medical, INC. | $101.46 | 2023-2025 | Gentlecath Glide |
| Bayer Healthcare Pharmaceuticals INC. | $97.91 | 2024-2025 | |
| Antares Pharma, INC. | $93.78 | 2022 | |
| Convatec INC. | $84.13 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $81.88 | 2023-2025 | Prolaris |
| Urogen Pharma, INC. | $80.20 | 2023-2024 | Jelmyto |
| Laborie Medical Technologies Corp. | $74.96 | 2024-2025 | Urgent PC Neuromodulation System |
| Progenics Pharmaceuticals, INC. | $68.80 | 2023-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $63.60 | 2019-2024 | Xiaflex |
| Blue Earth Diagnostics | $51.48 | 2021-2025 | Posluma |
| Healthtronics Stone Solutions, LLC | $48.12 | 2020 | |
| Abc Home Medical Supply, INC. | $42.27 | 2024 | |
| Abbott Laboratories | $34.90 | 2019-2023 | Axium |
| Myovant Sciences INC. | $28.99 | 2022 | |
| Calyxo, INC. | $28.23 | 2024 | Cvac Aspiration System |
| Avadel Specialty Pharmaceuticals, LLC | $27.47 | 2019 | |
| Hollister Incorporated | $25.18 | 2023 | Adapt Ceraring, New Image |
| Palette Life Sciences, INC. | $24.94 | 2022 | |
| Profound Medical Corp. | $23.56 | 2025 | Tulsa-Pro |
| Shire North American Group INC | $19.72 | 2019 | |
| Mission Pharmacal Company | $16.82 | 2020 | |
| Zyla Life Sciences, INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Donaldson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.